Charles Schwab Investment Management Inc Teva Pharmaceutical Industries LTD Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 899,175 shares of TEVA stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
899,175
Previous 721,339 24.65%
Holding current value
$15.3 Million
Previous $11.7 Million 38.24%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$15.81 - $18.96 $2.81 Million - $3.37 Million
177,836 Added 24.65%
899,175 $16.2 Million
Q2 2024

Aug 12, 2024
BUY
$12.78 - $17.4 $337,379 - $459,342
26,399 Added 3.8%
721,339 $11.7 Million
Q1 2024

May 08, 2024
BUY
$10.67 - $14.43 $301,896 - $408,282
28,294 Added 4.24%
694,940 $9.81 Million
Q4 2023

Feb 06, 2024
SELL
$8.12 - $10.63 $160,499 - $210,112
-19,766 Reduced 2.88%
666,646 $6.96 Million
Q3 2023

Nov 08, 2023
BUY
$7.48 - $10.7 $392,221 - $561,065
52,436 Added 8.27%
686,412 $7 Million
Q2 2023

Aug 09, 2023
BUY
$7.2 - $9.47 $156,535 - $205,887
21,741 Added 3.55%
633,976 $4.77 Million
Q1 2023

May 11, 2023
SELL
$8.36 - $11.37 $63,577 - $86,468
-7,605 Reduced 1.23%
612,235 $5.42 Million
Q4 2022

Feb 13, 2023
SELL
$7.95 - $9.48 $60,261 - $71,858
-7,580 Reduced 1.21%
619,840 $5.65 Million
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $163,014 - $283,967
23,763 Added 3.94%
627,420 $5.06 Million
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $130,522 - $183,934
17,686 Added 3.02%
603,657 $4.54 Million
Q1 2022

May 13, 2022
BUY
$7.33 - $9.39 $150,998 - $193,434
20,600 Added 3.64%
585,971 $5.5 Million
Q4 2021

Feb 11, 2022
BUY
$7.9 - $10.19 $138,036 - $178,049
17,473 Added 3.19%
565,371 $4.53 Million
Q3 2021

Nov 16, 2021
BUY
$8.38 - $10.18 $143,306 - $174,088
17,101 Added 3.22%
547,898 $5.34 Million
Q1 2021

May 17, 2021
BUY
$10.34 - $12.81 $283,140 - $350,776
27,383 Added 5.44%
530,797 $6.13 Million
Q4 2020

Feb 16, 2021
BUY
$8.61 - $11.04 $113,927 - $146,081
13,232 Added 2.7%
503,414 $4.86 Million
Q3 2020

Nov 13, 2020
BUY
$8.57 - $12.69 $105,908 - $156,823
12,358 Added 2.59%
490,182 $4.42 Million
Q2 2020

Aug 14, 2020
BUY
$8.12 - $13.12 $108,629 - $175,519
13,378 Added 2.88%
477,824 $5.89 Million
Q1 2020

May 15, 2020
BUY
$6.69 - $13.45 $285,937 - $574,866
42,741 Added 10.14%
464,446 $4.17 Million
Q4 2019

Feb 07, 2020
BUY
$6.53 - $10.72 $70,099 - $115,079
10,735 Added 2.61%
421,705 $4.13 Million
Q3 2019

Nov 08, 2019
BUY
$6.16 - $9.6 $99,576 - $155,184
16,165 Added 4.09%
410,970 $2.83 Million
Q2 2019

Aug 09, 2019
BUY
$8.12 - $15.72 $438,179 - $848,298
53,963 Added 15.83%
394,805 $3.65 Million
Q1 2019

May 14, 2019
BUY
$15.58 - $20.01 $204,643 - $262,831
13,135 Added 4.01%
340,842 $5.35 Million
Q4 2018

Feb 14, 2019
BUY
$14.59 - $23.84 $311,569 - $509,103
21,355 Added 6.97%
327,707 $5.05 Million
Q3 2018

Nov 13, 2018
BUY
$21.06 - $25.65 $192,025 - $233,876
9,118 Added 3.07%
306,352 $6.6 Million
Q2 2018

Aug 08, 2018
BUY
$16.77 - $24.71 $347,373 - $511,842
20,714 Added 7.49%
297,234 $7.23 Million
Q1 2018

May 07, 2018
BUY
$16.68 - $22.07 $193,504 - $256,034
11,601 Added 4.38%
276,520 $4.73 Million
Q4 2017

Jan 17, 2018
BUY
$11.23 - $19.1 $194,941 - $331,556
17,359 Added 7.01%
264,919 $5.02 Million
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $3.81 Million - $7.96 Million
247,560
247,560 $4.36 Million

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email